Article
Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Dementia and geriatric cognitive disorders - 1 Jan 2005
Bizzarro A, Marra C, Acciarri A, Valenza A, Tiziano F D, Brahe C, Masullo C
Abstract excerpt
The existence of an association between apolipoprotein E (APOE) and Alzheimer's disease (AD) has been reported in several studies. The possession of an ApoE epsilon4 allele is now considered a genetic risk factor for sporadic AD. There has been a growing agreement about the role exerted by the ApoE epsilon4 allele on the neuropsychological profile and the rate of cognitive decline in AD patients. However, a more...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
